Coronavirus first appeared in an outdoor market in Wuhan, China. Since then it has spread globally in just two weeks. More than 100 people have died from the virus, and confirmed cases have surpassed 5,500 worldwide. Coronavirus spreads so quickly that many airports are now conducting screenings in order to help with containment.
This type of global epidemic requires rapid research to determine how to contain and treat the disease. In epidemiology, research must be a shared effort between institutions worldwide. It’s also essential for companies, research institutions, governments, and technologists to collaborate on this time-sensitive effort to develop treatments and vaccines.
Artificial intelligence, with its ability to process and analyze enormous amounts of data, is providing the tools necessary to assist in the detection of the coronavirus, map the spread of the disease, and monitor and quarantine patients.
Time Sensitive Research and Development
Time-sensitive research and development in the field of epidemiology requires rapid information sharing on a global level. Often, there is no time to read carefully through existing research to find out what information is still needed. This “research on research” is conducted by scientists who are working on the front lines of vaccine and treatment development. Researchers need to find the institutions and contact details of people who have worked on previous related projects to speak with them directly.
Using ResoluteAI’s Foundation search tool, researchers around the world can easily access data visualizations to see which countries and institutions have been involved in coronavirus research. Below are the institutions that have previously received research grants for work on Coronavirus.
One can also easily see a breakdown of the amount of research conducted by research institutions versus universities or corporations.
The research institutions that are conducting clinical trials on Coronavirus, can also easily be plotted by year.
Finally, to find which countries have the most expertise in Coronavirus research, an analysis of the number of patents filed related to Coronavirus by country can be plotted. So far, the United States leads in the most patents filed. China, however, holds substantial patents in this area as well.
To prevent the spread of Coronavirus, it's important to understand how the virus will be transmitted by understanding the genetic profile and possible mutations of the virus.
Using ResoluteAI’s advanced search tool, researchers can search for publications that have referenced Coronavirus mutation or vaccines. There have been 57 articles published in this area to date.
Current Technology at A Glance
There are currently 13 different technology transfer opportunities related to Coronavirus. Research institutions such as Academia Sinica in Taiwan, and Ohio State University are trying to develop anti-Coronavirus compounds.
For an at-a-glance list all the institutions and publications involved in the development of anti-Coronavirus compounds, ResoluteAI can offer a clear illustration of the work being done:
The power of an AI-driven research tool like Foundation is that it can pull together corporate research, publications, patent information, technology transfer opportunities, clinical trials, and grant recipients into one seamlessly searchable environment. This not only saves researchers’ time but enables researchers to work with technologists, geneticists, pharmaceutical companies, and government agencies to ensure that knowledge can be communicated quickly and efficiently between different institutions. With global support, and meaningful scientific connections, the spread of Coronavirus can be controlled more effectively.